title: Metabotropic glutamate receptor 5 in schizophrenia: emerging evidence for the development of antipsychotic drugs.
authors.affiliation: Faculty of Science, Medicine & Health and Illawarra Health & Medical Research Institute, University of Wollongong, Northfields Avenue Wollongong, NSW, 2522 Australia. knewell@uow.edu.au.
authors.forename: Kelly A
authors.initials: KA
authors.lastname: Newell
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D055808:Drug Discovery; D006801:Humans; D058990:Molecular Targeted Therapy; D064529:Receptor, Metabotropic Glutamate 5 / Q000378:metabolism*; D012559:Schizophrenia / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D014150:Antipsychotic Agents; D064529:Receptor, Metabotropic Glutamate 5